M C53 (Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 250 mg)

Pill with imprint M C53 is Green, Round and has been identified as Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M C53

Carbidopa and Levodopa (Orally Disintegrating)

Imprint

M C53

Strength

25 mg / 250 mg

Color

Green

Size

15.00 mm

Shape

Round

Availability

Prescription only

Drug Class

Dopaminergic antiparkinsonism agents

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Mylan Pharmaceuticals Inc.

National Drug Code (NDC)

00378-5053

Inactive Ingredients

aspartame, mannitol, microcrystalline cellulose, silicon dioxide, sodium stearyl fumarate, sorbitol, FD&C Blue No. 1, D&C Yellow No. 10

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer